Toth Financial Advisory’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95K | Buy |
+40
| New | +$1.95K | ﹤0.01% | 628 |
|
|
2023
Q3 | – | Sell |
-5
| Closed | -$281 | – | 772 |
|
|
2023
Q2 | $281 | Sell |
5
-50
| -91% | -$2.81K | ﹤0.01% | 751 |
|
|
2023
Q1 | $2.49K | Hold |
55
| – | – | ﹤0.01% | 620 |
|
|
2022
Q4 | $2.24K | Hold |
55
| – | – | ﹤0.01% | 577 |
|
|
2022
Q3 | $4K | Hold |
55
| – | – | ﹤0.01% | 559 |
|
|
2022
Q2 | $3K | Hold |
55
| – | – | ﹤0.01% | 545 |
|
|
2022
Q1 | $3K | Hold |
55
| – | – | ﹤0.01% | 581 |
|
|
2021
Q4 | $4K | Hold |
55
| – | – | ﹤0.01% | 576 |
|
|
2021
Q3 | $6K | Hold |
55
| – | – | ﹤0.01% | 534 |
|
|
2021
Q2 | $9K | Hold |
55
| – | – | ﹤0.01% | 461 |
|
|
2021
Q1 | $7K | Sell |
55
-4
| -7% | -$509 | ﹤0.01% | 484 |
|
|
2020
Q4 | $9K | Hold |
59
| – | – | ﹤0.01% | 412 |
|
|
2020
Q3 | $5K | Hold |
59
| – | – | ﹤0.01% | 419 |
|
|
2020
Q2 | $4K | Buy |
59
+19
| +48% | +$1.29K | ﹤0.01% | 409 |
|
|
2020
Q1 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 372 |
|
|
2018
Q4 | – | Sell |
-100
| Closed | -$4K | – | 406 |
|
|
2018
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 364 |
|
|
2018
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 337 |
|
|
2018
Q1 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 357 |
|